Abstract
Rabies is a lethal zoonotic disease responsible for the deaths of 60,000 people annually. Rabies virus (RABV) is a lyssavirus prototype with a mortality rate of nearly 100% after symptom onset. Following an incubation period of 1-3 months after exposure, hosts develop encephalitis leading to two possible symptomatologies. A clinical presentation of RABV is encephalitic rabies, characterised by hydrophobia, agitation, and hypersalivation. Alternatively, RABV may also present as paralytic rabies, characterised by muscle weakness and paralysis. Both types eventually result in a comatose state followed by death. Despite mass vaccination campaigns in developing nations aiming to reduce infection across mammalian populations, the virus continues to gain prevalence in novel species and geographic areas, proving to be a threat of increasing magnitude.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
